JPWO2021173523A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021173523A5 JPWO2021173523A5 JP2022550891A JP2022550891A JPWO2021173523A5 JP WO2021173523 A5 JPWO2021173523 A5 JP WO2021173523A5 JP 2022550891 A JP2022550891 A JP 2022550891A JP 2022550891 A JP2022550891 A JP 2022550891A JP WO2021173523 A5 JPWO2021173523 A5 JP WO2021173523A5
- Authority
- JP
- Japan
- Prior art keywords
- cycloalkyl
- heterocycloalkyl
- alkyl
- optionally
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062980700P | 2020-02-24 | 2020-02-24 | |
| US62/980,700 | 2020-02-24 | ||
| US202063053565P | 2020-07-17 | 2020-07-17 | |
| US63/053,565 | 2020-07-17 | ||
| PCT/US2021/019181 WO2021173523A1 (en) | 2020-02-24 | 2021-02-23 | Hot melt extruded solid dispersions containing a bcl2 inhibitor |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023514750A JP2023514750A (ja) | 2023-04-07 |
| JPWO2021173523A5 true JPWO2021173523A5 (https=) | 2024-03-04 |
| JP2023514750A5 JP2023514750A5 (https=) | 2024-03-04 |
| JP7849296B2 JP7849296B2 (ja) | 2026-04-21 |
Family
ID=74875347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550891A Active JP7849296B2 (ja) | 2020-02-24 | 2021-02-23 | Ｂｃｌ２阻害剤を含むホットメルト押出し固体分散体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230295183A1 (https=) |
| EP (1) | EP4110298A1 (https=) |
| JP (1) | JP7849296B2 (https=) |
| KR (1) | KR20220158725A (https=) |
| CN (1) | CN115484933B (https=) |
| AU (1) | AU2021228622A1 (https=) |
| CA (1) | CA3173041A1 (https=) |
| IL (1) | IL295803A (https=) |
| MX (1) | MX2022010410A (https=) |
| WO (1) | WO2021173523A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4442685A4 (en) | 2021-12-06 | 2025-11-19 | Hangzhou Healzen Therapeutics Co Ltd | BCL-2 PROTEIN ANTI-APOPTOTIC INHIBITOR: PHARMACEUTICAL COMPOSITION AND USES |
| US11964990B2 (en) | 2022-01-21 | 2024-04-23 | Abbvie Inc. | 1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors |
| CN115894495B (zh) * | 2022-11-29 | 2024-08-09 | 大连理工大学 | 一种基于尿酸与苯硼酸衍生物复合晶体的纯有机室温磷光材料的制备方法 |
| CN116236583A (zh) * | 2023-03-30 | 2023-06-09 | 广州麓鹏制药有限公司 | 一种含Bcl-2/Bcl-xl抑制剂的组合物及其制备方法与应用 |
| CN116270660A (zh) * | 2023-03-30 | 2023-06-23 | 广州麓鹏制药有限公司 | 一种含Bcl-2/Bcl-xl抑制剂的组合物及其制备方法与应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19913692A1 (de) | 1999-03-25 | 2000-09-28 | Basf Ag | Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen |
| DE19929361A1 (de) | 1999-06-25 | 2001-01-04 | Basf Ag | Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen |
| WO2005049593A2 (en) | 2003-11-13 | 2005-06-02 | Abbott Laboratories | N-acylsulfonamide apoptosis promoters |
| US7790190B2 (en) | 2004-03-20 | 2010-09-07 | Yasoo Health, Inc. | Aqueous emulsions of lipophile solubilized with vitamin E TPGS and linoleic acid |
| WO2008064116A2 (en) | 2006-11-16 | 2008-05-29 | Abbott Laboratories | Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection |
| EP2231159A1 (en) | 2007-11-16 | 2010-09-29 | Abbott Laboratories | Method of treating arthritis |
| US20100297194A1 (en) * | 2009-04-30 | 2010-11-25 | Nathaniel Catron | Formulation for oral administration of apoptosis promoter |
| TWI540132B (zh) | 2009-06-08 | 2016-07-01 | 亞培公司 | Ｂｃｌ-２族群抑制劑之口服醫藥劑型 |
| UA113500C2 (xx) * | 2010-10-29 | 2017-02-10 | Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб | |
| CA3152557A1 (en) | 2010-10-29 | 2012-05-03 | Abbvie Inc. | Solid dispersions containing an apoptosis-inducing agent |
| CN106232144B (zh) * | 2014-03-18 | 2019-12-06 | 武田药品工业株式会社 | 固体分散体 |
| WO2017132474A1 (en) * | 2016-01-30 | 2017-08-03 | Newave Pharmaceutical Inc. | Bcl-2 inhibitors |
| EP3333167A1 (en) * | 2016-12-09 | 2018-06-13 | LEK Pharmaceuticals d.d. | Solid forms of venetoclax |
| AU2018322059C1 (en) | 2017-08-23 | 2024-09-12 | Guangzhou Lupeng Pharmaceutical Company Ltd. | BCL-2 inhibitors |
| US12220419B2 (en) * | 2018-08-22 | 2025-02-11 | Newave Pharmaceutical Inc. | BCL-2 inhibitors |
-
2021
- 2021-02-23 KR KR1020227033262A patent/KR20220158725A/ko active Pending
- 2021-02-23 IL IL295803A patent/IL295803A/en unknown
- 2021-02-23 CA CA3173041A patent/CA3173041A1/en active Pending
- 2021-02-23 JP JP2022550891A patent/JP7849296B2/ja active Active
- 2021-02-23 AU AU2021228622A patent/AU2021228622A1/en active Pending
- 2021-02-23 WO PCT/US2021/019181 patent/WO2021173523A1/en not_active Ceased
- 2021-02-23 EP EP21712350.4A patent/EP4110298A1/en active Pending
- 2021-02-23 CN CN202180016511.0A patent/CN115484933B/zh active Active
- 2021-02-23 MX MX2022010410A patent/MX2022010410A/es unknown
- 2021-02-23 US US17/798,904 patent/US20230295183A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3219308A1 (en) | Melt-extruded solid dispersions containing an apoptosis-inducing agent | |
| CN106660991B (zh) | 抗增殖化合物及其使用方法 | |
| IL295803A (en) | Hot melt extruded solid dispersions containing a bcl2 inhibitor | |
| CN101594851B (zh) | 用于口服给药的酪氨酸激酶抑制剂的药物剂型 | |
| CN103945848B (zh) | 被取代的喹唑啉酮的口服即释制剂 | |
| CN1343128B (zh) | 药物组合物 | |
| CN105899491A (zh) | 用于抑制shp2活性的1-哒嗪-/三嗪-3-基-哌(-嗪)/啶/吡咯烷衍生物及其组合物 | |
| JP6956725B2 (ja) | 抗増殖化合物、ならびにそれらの薬学的組成物及び使用 | |
| CN104173272B (zh) | 一种异硫氰酸酯类化合物的缓释制剂 | |
| RU2013124824A (ru) | Твердые дисперсии, содержащие средства, вызывающие апоптоз | |
| KR20160048807A (ko) | 과증식성 질병의 치료에서 사용하기 위한 mek 억제제 및 erk 억제제의 조합 | |
| JP2013540823A5 (https=) | ||
| TW200821298A (en) | Pharmaceutical compositions | |
| KR101848131B1 (ko) | 저용량 이리노테칸염산염 수화물을 함유하는 항종양제 | |
| JP2009541223A5 (https=) | ||
| RU2013130224A (ru) | Фармацевтические композиции | |
| KR20140108707A (ko) | (+)-2-[1-(3-에톡시-4-메톡시-페닐)-2-메탄술포닐-에틸]-4-아세틸아미노이소인돌린-1,3-디온의 제제 | |
| KR20100016048A (ko) | 타미바로텐 캡슐제 | |
| RU2017144574A (ru) | Пероральная композиция целекоксиба для лечения боли | |
| AU2015360006B2 (en) | Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with a quinazoline derivative | |
| ES2870562T3 (es) | Composiciones y procedimientos para el tratamiento del crecimiento celular anormal | |
| JPWO2021173523A5 (https=) | ||
| AU2015327509B2 (en) | Oral formulation of A-nor-5a androstane compound | |
| CN119970741A (zh) | 作为用于治疗脑癌之治疗剂的2-苯胺基嘧啶衍生物 | |
| US20240415777A1 (en) | Instant release pharmaceutical preparation of anticoagulant and preparation method therefor |